Table. Characteristics of All the Research Articles and the Top 100 AAS Articles Published in 2016.
| Characteristic | All Articles (N = 1050) | Top 100 Articles (based on AAS) |
|---|---|---|
| Journals, No. (%) | ||
| Neurology | 512 (48.8) | 45 |
| JAMA Neurology | 120 (11.4) | 28 |
| Brain | 215 (20.5) | 13 |
| The Lancet Neurology | 47 (4.5) | 9 |
| Annals of Neurology | 156 (14.9) | 5 |
| Altmetric score, median (IQR) | 18 (9-40) | 269 (197-441) |
| Citations, median (IQR) | 20 (11-35) | 33 (18-54) |
| Open access, median (%) | 769 (73.2) | 88 (88) |
| Social media mentions, median (IQR) | ||
| 12 (5-22) | 41 (21-75) | |
| News outlet | 1 (0-3) | 30 (21-46) |
| 1 (0-2) | 5 (2-10) | |
| Read on Mendeley | 40 (24-66) | 59 (39-111) |
| Neurological subspecialty, No. (%) | ||
| Cognitive neurology | 187 (17.8) | 27 |
| Cerebrovascular neurology | 189 (18.0) | 12 |
| Neuroimmunology | 123 (11.7) | 11 |
| Movement disorders | 128 (12.2) | 9 |
| Neuromuscular | 127 (12.1) | 9 |
| Epilepsy | 97 (9.2) | 6 |
| Neurotrauma | 23 (2.2) | 7 |
| Headache | 25 (2.4) | 4 |
| Pediatric | 36 (3.4) | 1 |
| Miscellaneous | 115 (11.0) | 14 |
| Study design, No. (%) | ||
| Observational studies | 895 (85.2) | 83 |
| Clinical trials | 63 (6.0) | 11 |
| Basic research | 92 (8.8) | 6 |
| Article topic, No. (%) | ||
| Neurocognition | 58 (5.5) | 14 |
| Lifestyle | 25 (2.4) | 14 |
| Pharmacological therapies | 96 (9.1) | 13 |
| Genetics | 126 (12.0) | 9 |
| Natural history of disease | 137 (13.0) | 7 |
| Non-pharmacological therapies | 58 (5.5) | 7 |
| Etiopathogenesis | 85(8.1) | 1 |
| Diagnosis | 90 (8.6) | 3 |
| Imaging | 100 (9.5) | 0 |
| Outcomes | 75 (7.1) | 2 |
| Epidemiology | 46 (4.4) | 9 |
| Brain networks | 45 (4.3) | 6 |
| Others/miscellaneous | 109 (10.4) | 15 |
Abbreviations: AAS, Altmetric attention score; IQR, interquartile range.